Bioton gets up to $117 mln financing from US fund
WARSAW, July 4 (Reuters) - Poland's troubled insulin maker, Bioton BOTN.WA, said on Saturday it had clinched a deal with U.S. investment fund GEM Global Yield Fund on financing worth as much as 363 million zlotys ($117 million). "The agreement guarantees Bioton financing at the level of 200 million zlotys over three years starting with the signature of the deal," Bioton said in a statement.
The company would also issue warrants to the investment fund worth almost 163 million zlotys and exchangeable for its shares.
Earlier in July Bioton, which reported a $6 million net loss in the first quarter of 2009, said it would issue 50 million zlotys ($16.12 million) in shares to its main shareholder, Polish tycoon Ryszard Krauze. (Writing by Gabriela Baczynska, Editing by Peter Blackburn)
© Thomson Reuters 2009 All rights reserved
Dubai Debt Fears
Banks outside the Gulf played down their exposure to Dubai debt, after fears the emirate could default and even derail world economic recovery prompted a sell-off in global markets. Full Article | Slideshow
One Year Later
Mumbai held tearful memorials and police staged a show of strength as it marked the first anniversary of militant raids that killed 166 people and pushed up tensions with Pakistan. Slideshow | Full Coverage
